Evolving epidemiology of hepatitis C virus

Smith, 1995, Variation of the hepatitis C virus 5′ non‐coding region: implications for secondary structure, virus detection and typing, J Gen Virol, 76, 1749, 10.1099/0022-1317-76-7-1749 World Health Organization. World Health Report, Geneva, Switzerland 1996. Di Bisceglie, 1991, The role of chronic viral hepatitis in hepatocellular carcinoma in the United States, Am J Gastroenterol, 86, 335 Fattovich, 1997, Morbidity and mortality in compensated cirrhosis type C: a retrospective follow‐up study of 384 patients, Gastroenterology, 112, 463, 10.1053/gast.1997.v112.pm9024300 Kiyosawa, 1990, Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus, Hepatology, 12, 671, 10.1002/hep.1840120409 Seeff, 1992, Long‐term mortality after transfusion‐associated non‐A, non‐B hepatitis, N Engl J Med, 327, 1906, 10.1056/NEJM199212313272703 The Global burden of Hepatitis C working Group, 2004, Global burden of disease (GBD) for hepatitis C, J Clin Pharmacol, 44, 20, 10.1177/0091270003258669 1997, Hepatitis C: global prevalence (update), Wkly Epidemiol Rec, 72, 341 Poynard, 2003, A comparison of fibrosis progression in chronic liver diseases, J Hepatol, 38, 257, 10.1016/S0168-8278(02)00413-0 Adler, 2002, Hepatitis C virus: the burden of the disease, Acta Gastroenterol Belg, 65, 83 Jeannel, 1998, Evidence for high genetic diversity and long‐term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa, J Med Virol, 55, 92, 10.1002/(SICI)1096-9071(199806)55:2<92::AID-JMV2>3.0.CO;2-I Martinson, 1996, Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children, J Med Virol, 48, 278, 10.1002/(SICI)1096-9071(199603)48:3<278::AID-JMV11>3.0.CO;2-9 Richard‐Lenoble, 1995, Hepatitis B, C, D, and E markers in rural equatorial African villages (Gabon), Am J Trop Med Hyg, 53, 338, 10.4269/ajtmh.1995.53.338 Koretz, 1993, Non‐A, non‐B post‐transfusion hepatitis. Looking back in the second decade, Ann Intern Med, 119, 110, 10.7326/0003-4819-119-2-199307150-00003 Aach, 1991, Hepatitis C virus infection in post‐transfusion hepatitis. An analysis with first‐ and second‐generation assays, N Engl J Med, 325, 1325, 10.1056/NEJM199111073251901 Alter, 1991, Analysis of the role of hepatitis C virus in transfusion‐associated hepatitis, 396 Hagan, 1999, Syringe exchange and risk of infection with hepatitis B and C viruses, Am J Epidemiol, 149, 203, 10.1093/oxfordjournals.aje.a009792 Tanaka, 1992, Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors, Am J Trop Med Hyg, 46, 460, 10.4269/ajtmh.1992.46.460 Broers, 1998, Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995, AIDS, 12, 2059, 10.1097/00002030-199815000-00018 Dutta, 1998, A prospective study on the incidence of hepatitis B & C infections amongst patients with lymphoproliferative disorders, Indian J Med Res, 107, 78 van Beek, 1998, Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study, BMJ, 317, 433, 10.1136/bmj.317.7156.433 Crofts, 1997, Epidemiology of hepatitis C virus infection among injecting drug users in Australia, J Epidemiol Community Health, 51, 692, 10.1136/jech.51.6.692 el‐Ahmady, 1994, Incidence of hepatitis C virus in Egyptians, J Hepatol, 21, 687, 10.1016/S0168-8278(94)80123-1 Fabrizi, 1998, Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay, Am J Kidney Dis, 31, 647, 10.1053/ajkd.1998.v31.pm9531181 2000, Hepatitis C—global prevalence (update), Wkly Epidemiol Rec, 75, 18 Shepard, 2005, Global epidemiology of hepatitis C virus infection, Lancet Infect Dis, 5, 558, 10.1016/S1473-3099(05)70216-4 1997, Hepatitis C: global prevalence, Wkly Epidemiol Rec, 72, 65 Moyer, 1999, Hepatitis C: part I. Routine serologic testing and diagnosis, Am Fam Physician, 59, 79 Shah, 2006, The economics of hepatitis C, Clin Liver Dis, 10, 717, 10.1016/j.cld.2006.08.026 Buti, 2005, Estimating the impact of hepatitis C virus therapy on future liver‐related morbidity, mortality and costs related to chronic hepatitis C, J Hepatol, 42, 639, 10.1016/j.jhep.2004.12.031 El Saadany, 2005, Economic burden of hepatitis C in Canada and the potential impact of prevention. Results from a disease model, Eur J Health Econ, 6, 159, 10.1007/s10198-004-0273-y Bao, 2009, Systematic review of HIV and HCV infection among drug users in China, Int J STD AIDS, 20, 399, 10.1258/ijsa.2008.008362 Xia, 2008, Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta‐analysis, Public Health, 122, 990, 10.1016/j.puhe.2008.01.014 Lu, 2009, General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross‐sectional study in 2007, PLoS ONE, 4, e8467, 10.1371/journal.pone.0008467 Li, 1998, Epidemiologic features of viral hepatitis in Fujian, Zhonghua Liu Xing Bing Xue Za Zhi, 19, 89 Zhang, 2005, Hepatitis C virus infection, Linxian, China, Emerg Infect Dis, 11, 17, 10.3201/eid1101.031005 Zhang, 2010, Alternative risk factors of HCV infection in a rural community in China, Epidemiol Infect, 138, 1032, 10.1017/S0950268809991269 Mukhopadhyaya, 2008, Hepatitis C in India, J Biosci, 33, 465, 10.1007/s12038-008-0065-0 Chung, 2010, Changing trends in hepatitis C infection over the past 50 years in Japan, Intervirology, 53, 39, 10.1159/000252782 D’Amelio, 2006, Stable low levels of hepatitis C virus infection among Italian young males over the past decade, Dig Liver Dis, 38, 64, 10.1016/j.dld.2005.09.017 Mariano, 2009, Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy, Scand J Infect Dis, 41, 689, 10.1080/00365540903095358 Waheed, 2009, Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors, World J Gastroenterol, 15, 5647, 10.3748/wjg.15.5647 Arthur, 1997, Hepatitis C antibody prevalence in blood donors in different governorates in Egypt, Trans R Soc Trop Med Hyg, 91, 271, 10.1016/S0035-9203(97)90070-5 el Gohary, 1995, High prevalence of hepatitis C virus among urban and rural population groups in Egypt, Acta Trop, 59, 155, 10.1016/0001-706X(95)00075-P Mohamed, 1996, Viral hepatitis C infection among Egyptians, the magnitude of the problem: epidemiological and laboratory approach, J Egypt Public Health Assoc, 71, 79 el‐Sayed, 1996, Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt, Am J Trop Med Hyg, 55, 179, 10.4269/ajtmh.1996.55.179 McOmish, 1994, Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey, J Clin Microbiol, 32, 884, 10.1128/JCM.32.4.884-892.1994 Mellor, 1995, Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification, J Gen Virol, 76, 2493, 10.1099/0022-1317-76-10-2493 Quinti, 1997, HCV infection in Egyptian patients with acute hepatitis, Dig Dis Sci, 42, 2017, 10.1023/A:1018897813268 Frank, 2000, The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, Lancet, 355, 887, 10.1016/S0140-6736(99)06527-7 Miller, 2010, Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt, Proc Natl Acad Sci USA, 107, 14757, 10.1073/pnas.1008877107 Razzaghi, 1999 Triki, 1997, Seroepidemiology of hepatitis B, C and delta viruses in Tunisia, Trans R Soc Trop Med Hyg, 91, 11, 10.1016/S0035-9203(97)90374-6 Darwish, 1996, High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study, Am J Trop Med Hyg, 54, 554, 10.4269/ajtmh.1996.54.554 Stevens, 2008, Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials, PLoS ONE, 3, e2043, 10.1371/journal.pone.0002043 Madzime, 2000, Seroprevalence of hepatitis C virus infection among indigent urban pregnant women in Zimbabwe, Cent Afr J Med, 46, 1 Muhlberger, 2009, HCV‐related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality, BMC Public Health, 9, 34, 10.1186/1471-2458-9-34 Sweeting, 2007, The burden of hepatitis C in England, J Viral Hepatol, 14, 570, 10.1111/j.1365-2893.2007.00851.x Hutchinson, 2002, Prevalence of hepatitis C among injectors in Scotland 1989–2000: declining trends among young injectors halt in the late 1990s, Epidemiol Infect, 128, 473, 10.1017/S0950268802006945 Hutchinson, 2005, Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland, Hepatology, 42, 711, 10.1002/hep.20836 Diagnosing viral hepatitis in the community Bukh, 1993, At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide, Proc Natl Acad Sci USA, 90, 8234, 10.1073/pnas.90.17.8234 Davidson, 1995, Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non‐coding region, J Gen Virol, 76, 1197, 10.1099/0022-1317-76-5-1197 Stuyver, 1996, Second‐generation line probe assay for hepatitis C virus genotyping, J Clin Microbiol, 34, 2259, 10.1128/JCM.34.9.2259-2266.1996 Li, 2009, Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong, J Med Virol, 81, 628, 10.1002/jmv.21430 Simmonds, 1994, A proposed system for the nomenclature of hepatitis C viral genotypes, Hepatology, 19, 1321, 10.1002/hep.1840190538 Stuyver, 1994, Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes, Proc Natl Acad Sci USA, 91, 10134, 10.1073/pnas.91.21.10134 Tokita, 1995, Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups, J Gen Virol, 76, 2329, 10.1099/0022-1317-76-9-2329 Tokita, 1994, Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups, Proc Natl Acad Sci USA, 91, 11022, 10.1073/pnas.91.23.11022 Tokita, 1994, Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group, J Gen Virol, 75, 931, 10.1099/0022-1317-75-4-931 Mellor, 1996, Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core‐based genotyping assay, J Clin Microbiol, 34, 417, 10.1128/JCM.34.2.417-423.1996 Ruggieri, 1996, Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry), J Gen Virol, 77, 2073, 10.1099/0022-1317-77-9-2073 Abergel, 2007, The epidemiology and virology of hepatitis C virus genotype 5 in central France, Aliment Pharmacol Ther, 26, 1437, 10.1111/j.1365-2036.2007.03530.x Bernier, 1996, Identification of numerous hepatitis C virus genotypes in Montreal, Canada, J Clin Microbiol, 34, 2815, 10.1128/JCM.34.11.2815-2818.1996 McCaw, 1997, Hepatitis C virus genotypes in Australia, J Viral Hepatol, 4, 351, 10.1046/j.1365-2893.1997.00060.x Markov, 2009, Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa, J Gen Virol, 90, 2086, 10.1099/vir.0.011569-0 Dore, 2003, Epidemiology of hepatitis C virus infection in Australia, J Clin Virol, 26, 171, 10.1016/S1386-6532(02)00116-6 Hepatitis C Virus Projections Working Group, 2002, Estimates and projections of the hepatitis C virus epidemic in Australia 2002 Zou, 2000, Prediction of hepatitis C burden in Canada, Can J Gastroenterol, 14, 575, 10.1155/2000/642707 Deuffic‐Burban, 2009, Modelling the past, current and future HCV burden in France: detailed analysis and perspectives, Stat Methods Med Res, 18, 233, 10.1177/0962280208094697 Deuffic‐Burban, 2007, Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States, J Viral Hepatol, 14, 107, 10.1111/j.1365-2893.2006.00785.x Sagnelli, 2005, The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases, J Med Virol, 75, 522, 10.1002/jmv.20313 Kim, 2008, Epidemiology of hepatocellular carcinoma in Japan and Korea. A review, Oncology, 75, 13, 10.1159/000173419 Tanaka, 2008, Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003, Ann Intern Med, 148, 820, 10.7326/0003-4819-148-11-200806030-00004 Rosen, 1999, Molecular epidemiology of hepatitis C infection in US veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B, Am J Gastroenterol, 94, 3015, 10.1111/j.1572-0241.1999.01456.x 1999, Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium, J Viral Hepatol, 6, 35 Alter, 1997, Epidemiology of Hepatitis C, Hepatology, 26, 62S, 10.1002/hep.510260711 1999, EASL International Consensus Conference on Hepatitis C. Consensus Statement, Journal of Hepatology, 31, 3, 10.1016/S0168-8278(99)80367-5 Pruss‐Ustun, 2005, Estimation of the global burden of disease attributable to contaminated sharps injuries among health‐care workers, Am J Ind Med, 48, 482, 10.1002/ajim.20230 FitzSimons, 2008, Hepatitis B virus, hepatitis C virus and other blood‐borne infections in healthcare workers: guidelines for prevention and management in industrialised countries, Occup Environ Med, 65, 446, 10.1136/oem.2006.032334 Perz, 2010, US outbreak investigations highlight the need for safe injection practices and basic infection control, Clin Liver Dis, 14, 137, 10.1016/j.cld.2009.11.004 Alavian, 2009, Hepatitis C infection in the general population of Iran: a systematic review, Hepat Mon, 9, 211